Chemoprotective effects of a recombinant protein from Pyropia yezoensis and synthetic peptide against acetaminophen-induced Chang liver cell death

Keywords : Pyropia yezoensis, Recombinant protein, Chemoprotective effect, Acetaminophen-induced cell de...

2021-05-18    |    669

Bioactive peptide from Pyropia yezoensis and its anti‑inflammatory activities

Keywords : Pyropia yezoensis, Bioactive peptide, Anti‑inflammation, RAW 264.7

2021-05-18    |    1216

Indispensable Role of CX3CR1+ Dendritic Cells in Regulation of Virus-Induced Neuroinflammation Through Rapid Development of Antiviral Immunity in Peripheral Lymphoid Tissues

Keywords : CX3CR chemokine receptor, Japanese encephalitis, Dendritic cells, Neuroinflammation, Antiviral imm...

2021-05-18    |    525

Double-faced implication of CD4+Foxp3+ regulatory T cells expanded by acute dengue infection via TLR2/MyD88 pathway

Keywords : Dengue virus, Hemorrhagic fever, MyD88, Regulatory T cells, TLR

2021-05-18    |    1438

Activation of Protein Kinase G After Repeated Cocaine Administration Is Necessary for the Phosphorylation of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor GluA1 at Serine 831 in the R

Keywords : NAc, Glutamate receptor, Protein kinase, Psychostimulant, Locomotor activity

2021-01-15    |    2216

N-terminal modification of the tetrapeptide Arg-Leu-Tyr-Glu, a vascular endothelial growth factor receptor-2 (VEGFR-2) antagonist, improves antitumor activity by increasing its stability against serum

Keywords : VEGFR-2, Peptidase, Peptide Degradation, Angiogenesis

2020-07-10    |    1224

Combined stimulation of TLR9 and 4.1BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTL activity and infiltration into tumor sites

Keywords : 4.1BB, Melanoma, Peptide vaccines, TLR9

2020-07-10    |    993

Optimized gemcitabine therapy in combination with E7 peptide immunization elicits tumor cure by preventing Ag-specic CTL

Keywords : Antitumor therapy, 4-1BB, CpG-ODN, Gemcitabine, Peptide vaccines, Tumor recurrence

2020-07-10    |    757

Tumor regression is mediated via the induction of HER2 63-71-specific CD8+ CTL activity in a 4T1.2/HER2 tumor model: no involvement of CD80 in tumor control

Keywords : Antitumor immunity, CD80, MDSCs, HER2, Tumor models

2020-07-07    |    1152

Therapeutic tumor control of HER2 DNA vaccines is achieved by an alteration of tumor cells and tumor microenvironment by gemcitabine and anti-Gr-1 ab treatment in a HER2-expressing tumor model

Keywords : Antitumor immunity, Gemcitabine, HER2 vaccines, Immune evasion, Myeloid-derived suppressor cells

2020-07-07    |    693